| Product Name | NebuSelect™ Recombinant PE-Labeled Human EGFRVIII, Avi-His-tag |
|---|---|
| Catalog Number | NBL-242723 |
| Alias/Synonyms | EGFRVIII; ErbB; EC 2.7.10; EC 2.7.10.1; EGFR; mENA; LEGFR; ERBB; ERBB1; HER1; PIG61; NISBD2 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | NP_001333870.1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242723-100ug | 100ug | Inquire | Inquire | |
| NBL-242723-1mg | 1mg | Inquire | Inquire | |
| NBL-242723-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant PE-Labeled Human EGFRVIII, Avi-His-tag
Catalog#:
NBL-242723
Description:
NebuSelect™ Recombinant PE-Labeled Human EGFRVIII, Avi-His-tag(Cat#NBL-242723) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Leu25-Ser378.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 41.6 kDa.
Target Name:
EGFRVIII; ErbB; EC 2.7.10; EC 2.7.10.1; EGFR; mENA; LEGFR; ERBB; ERBB1; HER1; PIG61; NISBD2
Target Information:
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.